COVID-19急性呼吸窘迫综合征中体外膜氧合启动标准的演变
本研究纳入2020年3月至2021年7月某大型区域医疗系统中被拒绝体外膜氧合(ECMO)的193例COVID-19急性呼吸窘迫综合征患者。研究中期实施限制性筛选标准后,30天死亡率从53%升至73%(P=0.010)。多系统器官衰竭、延长机械通气时间和高龄分别使死亡 odds 增加约11倍、4倍和4倍。
要点
- 260例ECMO咨询中193例被拒绝,30天死亡率为66%(n=117)。
- 实施限制性标准后30天死亡率从53%升至73%(P=0.010)。
- 多系统器官衰竭、延长通气时间和高龄与死亡 odds 增加相关。
核心结论
- 被拒绝ECMO的COVID-19急性呼吸窘迫综合征患者代表危重队列,研究后期疾病严重程度和30天死亡率增加,可能反映分层筛选标准及与转诊中心的持续教育和沟通。
研究设计与样本
- 回顾性纳入2020年3月至2021年7月某大型区域医疗系统中所有被拒绝ECMO支持的患者,研究中期实施限制性筛选标准将队列分为两组。
主要发现
- 260例ECMO咨询中193例被拒绝,咨询时71.0%(n=137)接受机械通气,38%(n=74)接受俯卧位通气和化学性麻痹。
- 30天死亡率为66%(n=117),实施限制性标准后从53%升至73%(P=0.010)。
- 多系统器官衰竭患者死亡 odds 增加11倍(OR 10.6;95% CI 1.7-65.2)。
- 延长机械通气时间患者死亡 odds 增加4倍(OR 3.5;95% CI 1.1-12.0)。
- 高龄患者死亡 odds 增加4倍(OR 4.4;95% CI 1.9-10.2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To understand the implications of a tiered extracorporeal membrane oxygenation (ECMO) criteria framework and the outcomes of patients with COVID-19 acute respiratory distress syndrome who we were consulted on for ECMO but ultimately declined. METHODS: All patients declined for ECMO support by a large regional health care system between March 2020 and July 2021 were included. Restrictive selection criteria were enacted midway through the study stratifying the cohort into 2 groups. Primary outcomes included 30-day mortality. Secondary outcomes included reasons for declining ECMO and survival stratified by phase. RESULTS: One hundred ninety-three patients with COVID-19 acute respiratory distress syndrome were declined for ECMO within the study period out of 260 ECMO consults. At the time of consult, 71.0% (n = 137) were mechanically ventilated and 38% (n = 74) were proned and chemically paralyzed. Thirty-day mortality was 66% (n = 117), which increased from 53% to 73% (P = .010) when restrictive criteria were enacted. Patients with multisystem organ failure, prolonged ventilator time, and advanced age had respectively an 11-fold (odds ratio, 10.6; 95% CI, 1.7-65.2), 4-fold (odds ratio, 3.5; 95% CI, 1.1-12.0), and 4-fold (odds ratio, 4.4; 95% CI, 1.9-10.2) increase in the odds of mortality. CONCLUSIONS: Patients with COVID-19 acute respiratory distress syndrome declined for ECMO represent a critically ill cohort. We observed an increase in the severity of disease and 30-day mortality in consults in the latter phase of our study period. These findings may reflect our use of tiered selection criteria coupled with ongoing education and communication with referring centers, sparing both patients likely to respond to medical therapy and those who were unsalvageable by ECMO.
引用
- Deitz RL, Thorngren CK, Seese LM, et al. Evolution of extracorporeal membrane oxygenation trigger criteria in COVID-19 acute respiratory distress syndrome. J Thorac Cardiovasc Surg. 2022. PMID: 36481061. doi:10.1016/j.jtcvs.2022.09.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。